0001593968-23-001008.txt : 20230615 0001593968-23-001008.hdr.sgml : 20230615 20230615165706 ACCESSION NUMBER: 0001593968-23-001008 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230613 FILED AS OF DATE: 20230615 DATE AS OF CHANGE: 20230615 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mayo Stephen CENTRAL INDEX KEY: 0001849061 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38693 FILM NUMBER: 231018179 MAIL ADDRESS: STREET 1: 2000 GALLOPING HILL RD CITY: KENILWORTH STATE: NJ ZIP: 07033 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allogene Therapeutics, Inc. CENTRAL INDEX KEY: 0001737287 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 823562771 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 457-2700 MAIL ADDRESS: STREET 1: 210 EAST GRAND AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 primary_01.xml PRIMARY DOCUMENT X0407 4 2023-06-13 0001737287 Allogene Therapeutics, Inc. ALLO 0001849061 Mayo Stephen 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 true false Stock Option (Right to Buy) 5.7 2023-06-13 4 A false 116120 0 A 2033-06-13 Common Stock 116120 116120 D Vesting in 12 equal monthly installments /s/Lillian Smith, Attorney-in-Fact 2023-06-15